Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Ark, P. van der
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(8)
+
-
Availability
Open access
(2)
+
-
Metadata Only
(7)
+
-
Creation Date
2017
(3)
+
-
2019
(3)
+
-
2018
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(8)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(8)
+
-
Topic
Depression
(2)
+
-
Author
Ark, P. van der
(9)
+
-
Gerven, J. van
(7)
+
-
Zuiker, R.
(7)
+
-
Boer, P. de
(6)
+
-
Luthringer, R.
(6)
+
-
Jacobs, G.
(4)
+
-
Nueten, L. van
(4)
+
-
Recourt, K.
(4)
+
-
Amerongen, G. van
(3)
+
-
Drevets, W.
(3)
+
-
Drevets, W.C.
(3)
+
-
Kezic, I.
(3)
+
-
Benes, H.
(2)
+
-
Brooks, S.
(2)
+
-
Fedgchin, M.
(2)
+
-
Gerven, J.M.A. van
(2)
+
-
Hove, I. van
(2)
+
-
Jacobs, G.E.
(2)
+
-
Kent, J.
(2)
+
-
Kent, J.M.
(2)
+
-
Singh, J.
(2)
+
-
Wajs, E.
(2)
+
-
Show more
Language
en
(9)
+
-
Search results
(1 - 9 of 9)
show grid
show list
save search
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder (vol 9, 216, 2019)
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia
A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity
Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study
JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder
The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia
